Diretor at Fudan University, China
Dr. Zhefeng Meng (PhD, MD) is an accomplished Associate Professor and Deputy Director of the Scientific Research Department at Minhang Hospital, Fudan University. With over two decades of research experience, his work spans HIV molecular evolution, viral-host interactions, cancer biomarker discovery, and tumor immunology. He has published extensively in leading journals such as J Hepatol, J Infect Dis, Front Immunol, and Cell Death & Disease, contributing significantly to both basic and translational biomedical sciences. Dr. Meng has secured multiple competitive research grants from the National Natural Science Foundation of China, Shanghai Science and Technology Commission, and various postdoctoral programs. His scientific excellence has earned him numerous honors, including the Leading Talent Award of Minhang District and prestigious international travel and scholarship grants. His current research focuses on improving early cancer diagnostics and advancing immunotherapeutic strategies, positioning him as a key contributor to global efforts in infectious disease control and cancer research.
Professional Profile
🎓 Education Background of Dr. Zhefeng Meng
Dr. Zhefeng Meng has built a strong and multidisciplinary academic foundation in medical sciences. He earned his Ph.D. in Medical Molecular Virology from the National Center for AIDS and STD Control and Prevention (China CDC) between 2005 and 2008, focusing on HIV gene variation and evolution. Prior to this, he completed a Master’s degree in Medical Molecular Biology at Wenzhou Medical College from 2001 to 2004, where he conducted research on fusion proteins and gene expression. His academic journey began with a College Diploma in Clinical Laboratory Medicine at Hubei College of Traditional Chinese Medicine from 1996 to 1999. This diverse educational background laid a solid foundation for his future contributions in virology, oncology, and immunology.
💼 Professional Experience of Dr. Zhefeng Meng
Dr. Zhefeng Meng has amassed extensive professional experience across leading medical and research institutions. Since 2015, he has served as an Associate Professor and Deputy Director of the Scientific Research Department at Minhang Hospital, Fudan University, where he leads cutting-edge studies on HIV recombination, syphilis and influenza evolution, and cancer biomarkers. Prior to this, from 2010 to 2015, he worked as an Associate Professor at the Shanghai Public Health Clinical Center, also affiliated with Fudan University, focusing on HIV-host protein interactions and viral replication mechanisms. From 2008 to 2010, Dr. Meng undertook postdoctoral research under Prof. Yumei Wen at Fudan University’s Key Laboratory of Medical Molecular Virology, where he studied therapeutic vaccines and HIV gene mutations. His earlier roles include Ph.D. research at China CDC, research assistantship at Taizhou Hospital, and work in the biotech industry, all of which contributed to his development as a versatile and impactful researcher in infectious diseases and oncology.
🔬 Research Interests of Dr. Zhefeng Meng
Dr. Zhefeng Meng’s research interests lie at the intersection of virology, immunology, and oncology, with a strong focus on infectious disease pathogenesis and tumor biology. He is particularly interested in the genetic evolution, recombination, and functional mutations of HIV, as well as their impact on viral infectivity, immune evasion, and host interactions. His work extends to studying early diagnostic biomarkers for liver and colorectal cancers, aiming to improve cancer detection and treatment strategies. Additionally, Dr. Meng explores the immune regulatory roles of viral proteins and develops novel immunotherapeutic approaches, such as peptide-based vaccines and fusion proteins. His interdisciplinary approach integrates molecular biology, clinical research, and translational science to address pressing global health challenges.
🏅 Awards and Honors of Dr. Zhefeng Meng
Dr. Zhefeng Meng has been widely recognized for his outstanding contributions to biomedical research through numerous national and international awards. He was honored as one of the Leading Talents of Minhang District in 2018 and received the First Rank Zhejiang Provincial Award for Medical and Health Technology Innovation in 2012. His excellence as a young scientist was acknowledged with Young Investigator Scholarships at both AIDS 2012 and AIDS Vaccine 2012, and he earned travel grants for global virology symposiums. Earlier in his career, he was named a Top PhD Student at China CDC and received multiple provincial awards for science and technology innovations. His consistent academic excellence was also marked by honors such as the Kwang-Hua Scholarship, Top Graduate Student distinction from Wenzhou Medical College, and leadership awards during his undergraduate years. These accolades reflect Dr. Meng’s sustained impact, innovation, and leadership in the fields of virology and medical science.
✅ Conclusion
Dr. Zhefeng Meng is a highly accomplished biomedical researcher with a sustained and impactful contribution to infectious disease research, oncology, and molecular medicine. His work is scientifically rigorous, clinically relevant, and nationally recognized. With high-quality publications, funded research projects, and strong institutional leadership, he exemplifies the criteria for the Best Researcher Award.
📄 Publication Top Noted
-
Title: TLR10 expression in unswitched memory B associates with the disease activity of patients with systemic lupus erythematosus
Authors: Lumin Zhang, Linchang Yu, Quanfu Li, Meiping Ni, Qiongzhu Dong, Yufang Bao, Jinguan Zhang, Danping Ruan, Zhefeng Meng*, Nannan Lai
Journal: Clinical Rheumatology
Year: 2025
Citations: 3
-
Title: Nesfatin-1 regulates the HMGB1-TLR4-NF-κB signaling pathway to inhibit inflammation and its effects on the random skin flap survival in rats
Authors: [Not fully visible]
Journal: International Immunopharmacology
Year: 2023
Citations: 7
-
Title: Roxadustat promotes hypoxia-inducible factor-1α/vascular endothelial growth factor signalling to enhance random skin flap survival in rats
Authors: [Not fully visible]
Journal: International Wound Journal
Year: 2023
Citations: 9
-
Title: Saxagliptin promotes random skin flap survival
Authors: [Not fully visible]
Journal: International Immunopharmacology
Year: 2023
Citations: 10
-
Title: Evidence of Residual Ongoing Viral Replication in Chronic Hepatitis B Patients Successfully Treated With Nucleos(t)ide Analogues
Authors: Yu T, Zhang M, Zhang H, Zheng J, Shen C, Jiang N, Zou L, Wang J, Yu Y, Zhang Q, Yu S, Huang Y, Huang Y, Zhang J, Qiu C*, Zhang W*, Meng Z*.
Journal: Journal of Infectious Diseases
Year: 2023
Citations: 6